| Literature DB >> 25496808 |
Haruhisa Kikuchi1, Toshiyuki Suzuki2, Masato Ogura2, Miwako K Homma2, Yoshimi Homma2, Yoshiteru Oshima3.
Abstract
Mitochondrial uncoupling is one of the therapeutic strategies used to control energy metabolism in various metabolic diseases and in obesity. Ppc-1 (1), a prenylated quinolinecarboxylic acid isolated from cellular slime molds, shows uncoupling activity in vitro and anti-obesity activity in vivo. In this study, we synthesized Ppc-1 (1) and its derivatives, and revealed the structure-activity relationship of uncoupling activities. The triprenylated compound 18 showed mitochondrial uncoupling activity that was more potent than that of Ppc-1 (1). Compound 18 also suppressed weight gain in mice without undesired effects such as lesions on tissues. These results indicate that compound 18 could be used as a seed compound for new anti-obesity drugs.Entities:
Keywords: Anti-obesity drugs; Metabolic diseases; Mitochondrial uncoupling; Quinolinecarboxylate; Structure–activity relationship
Mesh:
Substances:
Year: 2014 PMID: 25496808 DOI: 10.1016/j.bmc.2014.11.024
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641